Pleuratech ApS

PLEURATECH HAS DEVELOPED AN INSTRUMENT FOR INTRODUCING DRAINAGE INTO THE THORACIC CAVITY OF PATIENTS WITH A COLLAPSED LUNG OR WITH FLUID IN THE THORACIC CAVITY.

Problem
Insertion of tubes for drainage of fluid from the chest cavity is not optimal today, as there is no guarantee that the drain will work in the area of the chest cavity where drainage is needed.

Solution
With Pleuratech’s solution, KatGuide, the surgeon gets an innovative instrument that ensures better insertion and placement of the drain. It was developed by cardiac lung surgeon Niels Katballe from Aarhus University Hospital together with engineer Peter Heydorn.

Business
KatGuiden ensures greater efficiency in the treatment and therefore fewer complications and shorter hospitalization.

Market
There is a lung drainage market of approx. USD 250 million per year.

What has been accomplished?
Pleuratech’s technology has been sold to US drug company Merit Medical. Market launch is expected by 2021.

External investors

Founders

Founded in 2010

Have a look at some of our other companies

Read more about some of our other companies that are on their way to the top and others that have already made it.

Our current companies

Explore our entire portfolio

Success Stories

Companies that went all the way